Diarmuid M Moran

Summary

Affiliation: University of Chicago
Country: USA

Publications

  1. pmc Puromycin-based vectors promote a ROS-dependent recruitment of PML to nuclear inclusions enriched with HSP70 and Proteasomes
    Diarmuid M Moran
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, USA
    BMC Cell Biol 10:32. 2009
  2. pmc Nutlin-3a induces cytoskeletal rearrangement and inhibits the migration and invasion capacity of p53 wild-type cancer cells
    Diarmuid M Moran
    Rush University Medical Center, Department of Anatomy and Cell Biology, 1653 West Congress Parkway, Jelke 1306, Chicago, IL 60612, USA
    Mol Cancer Ther 9:895-905. 2010
  3. pmc Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors
    Michael J Breen
    Department of Medicine, Northwestern University, Chicago, Illinois, USA
    PLoS ONE 8:e72407. 2013
  4. pmc Transient nutlin-3a treatment promotes endoreduplication and the generation of therapy-resistant tetraploid cells
    Hong Shen
    Department of Radiation Oncology, University of Chicago, Chicago, Illinois60637, USA
    Cancer Res 68:8260-8. 2008

Collaborators

  • Michael J Breen
  • Hong Shen
  • Raymond C Bergan
  • Wenzhe Liu
  • Calvin P H Vary
  • Xiaoke Huang
  • Carl G Maki

Detail Information

Publications4

  1. pmc Puromycin-based vectors promote a ROS-dependent recruitment of PML to nuclear inclusions enriched with HSP70 and Proteasomes
    Diarmuid M Moran
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, USA
    BMC Cell Biol 10:32. 2009
    ..Previous studies reported that misfolded proteins or proteins containing polyglutamine tracts form aggregates with PML, chaperones, and components of the proteasome, supporting a role for PML in misfolded protein degradation...
  2. pmc Nutlin-3a induces cytoskeletal rearrangement and inhibits the migration and invasion capacity of p53 wild-type cancer cells
    Diarmuid M Moran
    Rush University Medical Center, Department of Anatomy and Cell Biology, 1653 West Congress Parkway, Jelke 1306, Chicago, IL 60612, USA
    Mol Cancer Ther 9:895-905. 2010
    ..Mol Cancer Ther; 9(4); 895-905. (c)2010 AACR...
  3. pmc Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors
    Michael J Breen
    Department of Medicine, Northwestern University, Chicago, Illinois, USA
    PLoS ONE 8:e72407. 2013
    ....
  4. pmc Transient nutlin-3a treatment promotes endoreduplication and the generation of therapy-resistant tetraploid cells
    Hong Shen
    Department of Radiation Oncology, University of Chicago, Chicago, Illinois60637, USA
    Cancer Res 68:8260-8. 2008
    ..These findings have important implications regarding the use of Nutlin-3a in cancer therapy..